.svg)
.svg)
.svg)
.svg){kind=icon}
.svg)
.svg){kind=icon}
.svg)
.svg){kind=icon}
.svg)
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
Publication date: November 12, 2024
- Year of incorporation: 1891
- Year added to the AEX: 1983
- Highest price ever: Approximately €54 in 2000
- Average trading volume: Approximately 3.2 million shares per day
- Price performance over the past 12 months: +24.68 %
Introduction about the company
Koninklijke Philips N.V. is a leading international technology company focused on health technology and consumer wellness. Headquartered in Amsterdam, Philips operates worldwide in medical devices, diagnostic solutions, and healthcare applications. Philips is listed on Euronext Amsterdam under the symbol PHIA and is known for its innovative and patient-centric approach within the healthcare sector.
Core figures & performance
In 2023, Philips achieved sales of approximately €18.2 billion and a net income of €-463 million. The company has about 70,000 employees worldwide and serves customers in the healthcare sector, including hospitals, clinics and healthcare facilities. Philips' market capitalization is approximately €25 billion measured in 2024. Philips maintains a dividend policy with stable distributions to shareholders, made possible by its profitability and continued focus on growth in the healthcare industry.
History & development
Philips was founded in 1891 as a manufacturer of light bulbs and grew to become one of the largest electronics companies in the world. Over the decades, Philips has shifted its focus to healthcare technology, and the company has retired from consumer electronics to focus entirely on the healthcare sector. In recent years, Philips has made strategic acquisitions, including those of companies such as Respironics and Volcano, to strengthen its position in medical imaging, monitoring systems, and sleep apnea solutions.
Sector & competition
Philips operates within the global healthcare sector, in which it competes with companies such as Siemens Healthineers, General Electric Healthcare and Medtronic. The sector is characterized by rapid technological advances and increasing demand for innovative healthcare solutions. Philips stands out for its strong focus on preventive care, connectivity and solutions that improve healthcare outcomes and reduce costs. The growing demand for digital and remotely managed care services strengthens Philips' position as an innovator in healthcare technology.
Influence of Philips on the AEX
With a weighting of about 2% in the AEX index (measured in 2024), Philips has a significant influence on the Dutch stock market index. Philips' share price is often sensitive to developments within the healthcare sector and is influenced by announcements of new products and quarterly results. As one of the larger health technology companies within the AEX, share price changes in Philips can affect the broader index, especially in the event of major strategic announcements or product launches.
Investment analysis & outlook
Investment analysts view Philips as a stable investment with growth potential in the rapidly evolving healthcare sector. Philips' focus on health technology offers significant growth opportunities, although the company has also faced challenges such as product recalls and regulatory issues. Analysts remain positive about Philips' long-term outlook, given its strong position in medical imaging, patient monitoring, and home care solutions, and its robust investments in research and development to develop new technologies.
Over the past five years, Philips shares have fluctuated significantly, highlighting the company's sensitivity to sector-specific changes. Despite efforts to respond to the growing demand for digital and connected health solutions, financial results have been disappointing during this period. This is reflected in the share price performance relative to the AEX below.
News & updates
Recently, Philips announced that it will intensify its efforts in digital health and AI-driven diagnostics to expand its offering of advanced healthcare solutions. The company is also targeting new markets and partnerships to increase its impact on global healthcare outcomes. These initiatives are part of Philips' long-term strategy to maintain and strengthen its leading role in healthcare technology. For more information on Royal Philips' performance and strategic plans, please visit its official website: Philips.com
Disclaimer: Investing involves risk. Our analysts are not financial advisors. Always consult an advisor when making financial decisions. The information and tips provided on this website are based on our analysts' own insights and experiences. They are therefore for educational purposes only.
.webp)
.webp)
.webp)
